Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 41.56 | 36.16 | -63.39 | 56.75 |
Depreciation/ Depletion | 3.26 | 3.01 | 3.08 | 2.82 |
Non- Cash Items | 6.16 | 9.93 | 98.30 | 6.98 |
Changesin Working Capital | 29.51 | -10.74 | -20.95 | -65.43 |
Cashfrom Operating Activities | 80.50 | 38.37 | 17.04 | 1.11 |
Capital Expenditures | -8.39 | -2.55 | -1.12 | -3.86 |
Other Investing Cash Flow Items Total | -19.01 | -0.34 | -18.75 | -6.42 |
Cashfrom Investing Activities | -27.40 | -2.88 | -19.87 | -10.28 |
Financing Cash Flow Items | -9.11 | -10.12 | -10.61 | -8.82 |
Total Cash Dividends Paid | -3.80 | -3.80 | -3.80 | - |
Issuance( Retirement)of Debt Net | -0.77 | 12.25 | -7.82 | 25.22 |
Cashfrom Financing Activities | -13.68 | -1.67 | -22.23 | 16.40 |
Net Changein Cash | 39.41 | 33.81 | -25.05 | 7.23 |
Cash Interest Paid | 9.11 | 10.12 | 10.61 | 8.82 |
Cash Taxes Paid | 0.34 | 0.92 | 2.88 | 0.30 |
Nath Bio Genes India Dividend Nath Bio Genes India Bonus Nath Bio Genes India News Nath Bio Genes India AGM Nath Bio Genes India Rights Nath Bio Genes India Splits Nath Bio Genes India Board Meetings Nath Bio Genes India Key Metrics Nath Bio Genes India Shareholdings Nath Bio Genes India Profit Loss Nath Bio Genes India Balance Sheet Nath Bio Genes India Q1 Results Nath Bio Genes India Q2 Results Nath Bio Genes India Q3 Results Nath Bio Genes India Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks